TMCnet News
UPDATE - Efferent Labs Expands Development Collaboration with GoreCHARLESTON, S.C., May 06, 2021 (GLOBE NEWSWIRE) -- Today, Efferent Labs announces an expanded development collaboration with W. L. Gore & Associates, Inc. (Gore) to explore the utility of Gore’s technology in Efferent’s “Living Informatics” CytoComm™ platform. As part of the effort, Efferent will partner with Gore to leverage the materials science company’s advanced technology to discover how it may enhance the CytoComm™ platform’s capabilities, such as enabling the sensor to more readily sample the environment surrounding the implanted device. “Having world-class expertise in materials science from Gore is going to be key to expanding the potential uses for the CytoComm™ platform. We are already working with their life science team to optimize the materials within our sensor,” said Bill Rader, CEO at Efferent, referencing the joint collaboration that began in August 2020. “Building on our relationship and leveraging the infrastructure within Gore will vastly accelerate our commercialization strategy.” “We are intrigued and excited about the potential impact the CytoComm™ platform will have on advancing the field of Living Informatics and see this as an arena were Gore’s expertise in advanced materials can further optimize the platform,” said Justin Skaife, Ph.D., Exploratory Research Leader at Gore. “This effort also lends alternative opportunities to further innovate with our advanced materials and bio-interface capabilities.” About Efferent Labs About Gore Media Contact: |